Maria Eugenia
De La Morena Barrio
Investigador "Ramon y Cajal"
KU Leuven
Lovaina, BélgicaPublikationen in Zusammenarbeit mit Forschern von KU Leuven (7)
2021
-
Antithrombin pThr147Ala: The First Founder Mutation in People of African Origin Responsible for Inherited Antithrombin Deficiency
Thrombosis and Haemostasis, Vol. 121, Núm. 2, pp. 182-191
2019
-
International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up
Journal of Inherited Metabolic Disease, Vol. 42, Núm. 1, pp. 5-28
2016
-
Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect
Journal of Thrombosis and Haemostasis, Vol. 14, Núm. 8, pp. 1549-1560
-
Natural killer cell receptors and cytotoxic activity in phosphomannomutase 2 deficiency (PMM2-CDG)
PLoS ONE, Vol. 11, Núm. 7
2014
-
Proteomic analysis of platelet N-glycoproteins in PMM2-CDG patients
Thrombosis Research, Vol. 133, Núm. 3, pp. 412-417
2013
-
GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients
Orphanet Journal of Rare Diseases, Vol. 8, Núm. 1
2012
-
Congenital disorder of glycosylation (PMM2-CDG) in a patient with antithrombin deficiency and severe thrombophilia
Journal of Thrombosis and Haemostasis